IL-36γ drives skin toxicity induced by EGFR/MEK inhibition and commensal Cutibacterium acnes-Reference-Cited by-同舟云学术

IL-36γ drives skin toxicity induced by EGFR/MEK inhibition and commensal Cutibacterium acnes

Published:2020-02-04 Issue:3 Volume:130 Page:1417-1430
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Satoh Takashi K.,Mellett Mark^ORCID,Meier-Schiesser Barbara^ORCID,Fenini Gabriele^ORCID,Otsuka Atsushi,Beer Hans-Dietmar,Rordorf Tamara,Maul Julia-Tatjana,Hafner Jürg,Navarini Alexander A.,Contassot Emmanuel,French Lars E.^ORCID

Funder

Swiss National Science Foundation

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/128678/files/pdf

Reference65 articles.

1. The epidermal growth factor receptor: from development to tumorigenesis

2. EGFR Antagonists in Cancer Treatment

3. MEK1 and MEK2 inhibitors and cancer therapy: the long and winding road

4. The clinical development of MEK inhibitors

5. Mechanisms of cutaneous toxicities to EGFR inhibitors

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer Therapy-induced Dermatotoxicity as a Window to Understanding Skin Immunity;Hematology/Oncology Clinics of North America;2024-10

2. CHANGES IN CYTOKINE PROFILE AS A CRITERION FOR SEVERITY PREDICTION OF SKIN TOXICITY IN CANCER PATIENTS RECEIVING EGFRi.;Russian Journal of Skin and Venereal Diseases;2024-09-08

3. Hepatotoxicity of epidermal growth factor receptor - tyrosine kinase inhibitors (EGFR-TKIs);Drug Metabolism Reviews;2024-08-09

4. Molecular aspects of Interleukin-36 cytokine activation and regulation;Biochemical Society Transactions;2024-06-28

5. Topical JAK inhibition ameliorates EGFR inhibitor–induced rash in rodents and humans;Science Translational Medicine;2024-06-19